Posted: Jan 21, 2026
What Is Head and Neck Cancer?
Head and neck cancer is a collective term used to describe a group of malignant tumors that arise in the upper aerodigestive tract. These cancers most commonly originate in the oral cavity, pharynx (nasopharynx, oropharynx, hypopharynx), larynx, and related structures such as the salivary glands. The majority are squamous cell carcinomas, reflecting their origin from the mucosal lining of these regions.
Although often discussed as a single entity, head and neck cancer encompasses a biologically and clinically diverse group of diseases, each with distinct risk factors, behavior, and treatment strategies. What they share is their potential impact on essential human functions—speech, swallowing, breathing, and appearance—making their management uniquely complex.
Epidemiology and Risk Factors
Head and neck cancer represents a significant global health burden. Traditional risk factors include tobacco use and alcohol consumption, which act synergistically to increase cancer risk. In recent decades, however, the epidemiology of these tumors—particularly oropharyngeal cancer—has changed dramatically.
A major driver of this shift is human papillomavirus (HPV) infection, especially HPV type 16. HPV-related oropharyngeal cancers typically affect younger patients, often without a history of smoking or heavy alcohol use. Importantly, these tumors show distinct biological behavior and a more favorable prognosis compared with HPV-negative cancers, a fact that increasingly influences treatment strategies.
Other recognized risk factors include poor oral hygiene, occupational exposures, prior radiation therapy, and certain genetic predispositions, although these play a secondary role compared to tobacco, alcohol, and HPV.
Clinical Presentation and Diagnosis
Symptoms of head and neck cancer depend on the tumor location but often include (please consult your otolaryngologist if you have any of the following):
- Persistent sore throat or mouth ulcer
- Difficulty or pain when swallowing
- Voice changes or hoarseness
- A neck mass due to lymph node involvement
- Unexplained weight loss or bleeding
Diagnosis relies on a combination of clinical examination, endoscopy, imaging (CT, MRI, PET-CT), and histological confirmation by biopsy. Accurate staging, based on the TNM classification, is essential and increasingly incorporates HPV status in oropharyngeal cancer, reflecting its prognostic significance.
The Importance of Multidisciplinary Management
One of the defining principles of modern head and neck cancer care is the multidisciplinary team (MDT) approach. Optimal management requires close collaboration between:
- Head and neck surgeons
- Radiation oncologists
- Medical oncologists
- Radiologists and pathologists
- Speech and swallowing therapists
- Nutrition specialists and nursing staff
Treatment decisions are made by balancing oncologic control with functional preservation and quality of life. This is particularly critical in head and neck cancer, where survival alone is not an adequate measure of success.
Treatment Strategies and Care Pathways
Treatment schemes depend on tumor site, stage, HPV status, and patient-related factors. The main therapeutic modalities are surgery, radiotherapy, and systemic therapy, used alone or in combination.
- Early-stage tumors may be treated with single-modality therapy, either surgery or radiotherapy.
- Locally advanced disease often requires combined approaches, such as surgery followed by adjuvant radiotherapy or chemoradiotherapy.
- Recurrent or metastatic disease may require individualized strategies including salvage surgery, re-irradiation, or systemic treatments.
Supportive care, including nutritional support and rehabilitation, is an integral part of every treatment pathway.
The Role of Robotic Surgery in Head and Neck Cancer
The introduction of transoral robotic surgery (TORS) has significantly expanded surgical options for selected head and neck cancers, particularly in the oropharynx.
TORS allows tumors to be removed through the mouth without external incisions, offering:
- Excellent visualization of deep anatomical areas
- Precise tumor resection with clear margins
- Reduced surgical morbidity
- Faster recovery of swallowing and speech in many patients
In HPV-related oropharyngeal cancer, TORS plays a key role in treatment de-escalation strategies, allowing surgery to replace or reduce the intensity of radiotherapy and chemotherapy in selected cases, thereby minimizing long-term toxicity.
Robotic surgery does not replace other treatments but integrates into multimodal, patient-centered care pathways, guided by MDT discussion and evidence-based protocols.
Current Trends and Future Directions
Advances in imaging, molecular characterization, and surgical technology continue to refine head and neck cancer management. While molecular pathways are increasingly understood, their main clinical impact currently lies in risk stratification and treatment personalization, rather than routine targeted therapy.
Future directions include:
- Further refinement of HPV-related tumors treatment strategies
- Expansion of minimally invasive surgical approaches
- Improved functional and quality-of-life outcomes
- New systemic treatment based on immunotherapy (monoclonal antibodies)
In summary, HNC is a diverse group of diseases affecting critical functions. Multidisciplinary management is essential for optimal outcomes. Robotic surgery has transformed the surgical management of selected tumors, especially in the oropharynx, improving functional outcomes. Modern care focuses on both survival and long-term quality of life.
J Granell
